Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DWB8C5
|
|||
| Drug Name |
VLA15
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Lyme disease [ICD-11: 1C1G; ICD-10: A69.2; ICD-9: 88.81] | Phase 2 | [1] | |
| Company |
Pfizer; Valneva
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03970733) Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.